Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Shigematsu Works Co., Ltd. specializes in the manufacturing of advanced medical instruments and supplies, particularly in respiratory and anesthesia products. The company operates primarily in Japan and has a growing international presence, leveraging its strong brand reputation and innovative technology to capture market share in an expanding healthcare sector.
Shigematsu generates revenue through the sale of high-quality medical instruments, focusing on respiratory and anesthesia markets. The company benefits from strong pricing power due to its established brand and reputation for quality, enabling it to maintain healthy gross margins despite competitive pressures.
Regulatory approvals for new medical devices
Changes in healthcare spending in Japan and abroad
Advancements in respiratory and anesthesia technologies
Market share gains in international markets
Technological disruption from new entrants in the medical device space
Regulatory changes impacting product approvals and market access
Intensifying competition from global medical device manufacturers
Potential price erosion due to increased competition
Free cash flow challenges due to high capital expenditures
Moderate leverage could become a concern if operating performance declines
moderate - The company's performance is linked to healthcare spending, which tends to be resilient but can be affected by broader economic conditions.
Rising interest rates could increase financing costs for capital expenditures, potentially impacting expansion plans and profitability. However, the company is not heavily reliant on debt, mitigating some risk.
minimal - The company has a manageable debt-to-equity ratio of 0.81, indicating limited reliance on external credit.
value - The company's low valuation multiples (P/S of 0.4x) may attract value investors looking for turnaround potential.
moderate - The stock has shown a 3-month return of -22%, indicating potential volatility in the near term.
